THW News and Press, Tekla World Healthcare Fund Shares of Beneficial Interest From 02/12/20

The WSJ reports that some of the 200 coronavirus test kits developed by the CDC and shipped to U.S. and international laboratories may not work properly. More news on: Co-Diagnostics, Inc., Tekla World Healthcare Fund, BlackRock Health Sciences Trust, Healthcare stocks news, News on ET...

The latest figures for the coronavirus outbreak are 40,171 reported infections with 908 deaths, almost all still confined to Wuhan and the surrounding Hubei province in China. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Wellnes...

Co-produced by Stanford Chemist SEC form N-2 is an important form to watch out for when a closed-end fund files with the SEC. This form must be submitted by any CEF when they register to offer shares. This is either through a primary offering or a secondary offering. We had covered this...

In today's update from the CDC, the total number of potential coronavirus cases in the U.S. is 337. Specimens tested to date include 12 positives, 225 negatives and 100 pending. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Welln...

In an update released today, the Centers for Disease Control and Prevention (CDC) reported that 293 Americans (previously 260) are under investigation for coronavirus infection, 11 positives, 206 negatives and 76 pending. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences...

The effects of the coronavirus outbreak in China, specifically the actions taken by governments and certain private sector companies to contain the spread of the respiratory ailment, are being felt across a wide swath of the globe's economy. More news on: Tekla World Healthcare Fund, Bla...

After a few months of research, head-scratching and decision-making I have completed the rebalancing of the Protected Principal Retirement Portfolio ((PPRP)). With changing world (and local) scenarios, I continue to hold about 12-15% cash reserves in the event that the correction I have been w...

Faced with pushback from multiple fronts over high drug prices, biopharmaceutical firms are experimenting with new ways to get paid for their priciest offerings, mostly biologics, in a report from the WSJ. More news on: Alnylam Pharmaceuticals, Inc., Sanofi, Novartis AG, Healthcare stock...

The new budget proposed by California Governor Gavin Newsom includes a plan to allow the state to contract with generic drug makers to provide medicines to all Californians. He believes that the government's purchasing power may be sufficient to cut drug prices to the state's 40M residents...

Results from a new study showed that end-of-year drug approvals by the FDA are linked to more hospitalizations, life-threatening events and deaths, a rate about twice as high as medicines approved earlier in the year. More news on: ProShares Trust - ProShares Ultra Nasdaq Biotechnology,...